Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial - 28/11/12
, Peter S. Pang, MD c, Mary J. Kwasny, ScD c, Andrew P. Ambrosy, MD d, Muthiah Vaduganathan, MD, MPH e, Christopher M. O'Connor, MD a, Karl Swedberg, MD, PhD f, Faiez Zannad, MD g, Marvin A. Konstam, MD h, Aldo P. Maggioni, MD iRésumé |
Background |
Heart failure (HF) complicated by atrial fibrillation/flutter (AF/AFL) is associated with worse outcomes. However, the clinical profile and outcomes of patients following hospitalization for HF with AF/AFL on initial electrocardiogram (ECG) has not been well studied.
Methods |
EVEREST was a randomized trial of vasopressin-2 receptor blockade, in addition to standard therapy, in 4133 patients hospitalized with HF with ejection fraction ≤40%. A post hoc analysis was performed comparing the clinical characteristics and outcomes [all-cause mortality and cardiovascular mortality/HF hospitalization] of patients with AF/AFL versus sinus rhythm (SR) on baseline ECG, which were centrally analyzed. Times to events were compared using log-rank tests and Cox regression models.
Results |
Of the 4133 patients, 1195 (29%) were classified with AF/AFL and 2071(50%) with SR. The remaining patients (21%) were excluded because ECGs were unavailable (n = 106), rhythm was paced (n = 727), or junctional/other supraventricular (n = 34). AF/AFL patients were older, with increased weight, faster heart rate, higher blood urea nitrogen, and natriuretic peptide levels compared to SR patients. Anticoagulation was prescribed in 67% of AF/AFL patients on discharge. AF/AFL patients were less likely to receive β-blockers or angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (all P < .05). After risk adjustment, AF/AFL was associated with increased mortality (hazard ratio 1.23; 95% CI, 1.04-1.46) and cardiovascular mortality/HF hospitalization (hazard ratio 1.26; 95% CI, 1.07-1.47).
Conclusion |
AF/AFL on initial ECG in patients hospitalized with HF with reduced ejection fraction is associated with lower use of evidence-based therapies and increased mortality and rehospitalization compared to patients in SR.
Le texte complet de cet article est disponible en PDF.Plan
| Hector O. Ventura, MD served as guest editor for this article. |
Vol 164 - N° 6
P. 884 - décembre 2012 Retour au numéro
Article précédent
- The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
- Lars Gullestad, Thor Ueland, John Kjekshus, Ståle H. Nymo, Johannes Hulthe, Pieter Muntendam, John J.V. McMurray, John Wikstrand, Pål Aukrust
- Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: A double-blind randomized controlled feasibility study
- Martin Stout, Garry A. Tew, Helen Doll, Irena Zwierska, Nicola Woodroofe, Kevin S. Channer, John M. Saxton
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?